SEARCH

SEARCH BY CITATION

References

  • Allison, A.C. & Eugui, E.M. (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology, 47, 85118.
  • Bellucci, S., Damaj, G., Boval, B., Rocha, V., Devergie, A., Agha, I.Y., Garderet, L., Ribaud, P., Traineau, R., Socie, G. & Gluckman, E. (2000) Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization. Bone Marrow Transplantation, 25, 327330.
  • Benny, W.B., Sutton, D.M., Oger, J., Bril, V., McAteer, M.J. & Rock, G. (1999) Clinical evaluation of a staphylococcal protein A immunoadsorption system in the treatment of myasthenia gravis patients. Transfusion, 39, 682687.
  • Boughton, B.J., Payne, A., Serman, A. & Owen, C. (1990) Elective surgery in a haemophiliac patient with high titre inhibitors: use of extracorporeal protein A immunoadsorption. Journal of Clinical Pathology, 43, 172.
  • Braun, N., Erley, C., Klein, R., Kotter, I., Saal, J. & Risler, T. (2000) Immunoadsorption on protein A induces remission in severe systemic lupus erythematosus. Nephrology Dialysis and Transplantation, 15, 13671372.
  • Caen, J.P., Castaldi, P.A., Leclerc, J.C., Incerman, S., Larrieu, M.J., Probst, M. & Bernard, J. (1966) Congenital bleeding disorders with long bleeding time and normal platelet count. Glanzmann's thrombasthenia (report of fifteen patients). American Journal of Medicine, 41, 426.
  • Fischer, A. (1991) Anti-LFA-1 antibody as immunosuppressive reagent in transplantation. Chemical Immunology, 50, 8997.
  • Gailani, D. (1992) An IgG inhibitor against coagulation factor XIII: resolution of bleeding after plasma immunoadsorption with staphylococcal protein A. American Journal of Medicine, 92, 110113.
  • George, J.N., Caen, J.P. & Nurden, A.T. (1990) Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood, 75, 13831395.
  • Gjörstrup, P. & Watt, R.M. (1990) Therapeutic protein A immunoadsorption: a review. Transfusion Science, 11, 281302.
  • Guillet, B., Kriaa, F., Huysse, M.G., Proulle, V., George, C., Tchernia, G., D'Oiron, R., Laurian, Y., Charpentier, B., Lambert, T. & Dreyfus, M. (2001) Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia. British Journal of Haematology, 114, 837844.
  • Gutensohn, K., Zander, A.R., Rowley, S.D., Hester, J. & Kuehnl, P. (1998) Protein A immunoadsorption in alloimmunized patients refractory to platelet transfusions and in patients with treatment-resistant immune thrombocytopenic purpura. Transfusion Science, 19, 4752.
  • Han, P. & Ardlie, N.G. (1974) The influence of pH, temperature and calcium on aggregation: the maintenance of environmental pH and platelet function for in vitro studies in plasma stored at 37°C. British Journal of Haematology, 26, 373375.
  • Kiefel, V., Santoso, S., Weisheit, M. & Mueller-Eckhardt, C. (1987) Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood, 70, 17221726.
  • Kiss, J.E., Oral, A., Ragni, M.V., Watt, R.M. & Starzl, T.E. (1989) Extracorporeal immunoadsorption for congenital FXI deficiency with FXI inhibitor undergoing liver transplantation. Blood, 74, 33.
  • Kriaa, F., Laurian, Y., Hiesse, C., Tchernia, G. & Charpentier, B. (1995) Five year's experience at one centre with protein A immunoadsorption in patients with deleterious allo-antibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosis. Nephrology Dialysis and Transplantation, 10, 108110.
  • Lethagen, S. & Nilsson, I.M. (1992) DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb–IIIa. European Journal of Haematology, 49, 713.
  • Nurden, A.T. & George, J.N. (2001) Inherited abnormalities of the platelet membrane: Glanzmann thrombasthenia, Bernard–Soulier syndrome, and other disorders. In: Hemostasis & Thrombosis. Basic Principles & Practice 4th edn. (ed. by R.W.Colman, J.Hirsh, V.J.Marder, A.W.Clowes & J.N.George ), pp. 921943. Lippincott, Williams & Wilkins, Philadelphia.
  • D'Oiron, R., Menart, C., Trzeciak, M.C., Nurden, P., Fressinaud, E., Dreyfus, M., Laurian, Y. & Negrier, C. (2000) Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thrombosis and Haemostasis, 83, 644647.
  • Patel, R.K., Savidge, G.F. & Rangarajan, S. (2001) Use of recombinant factor VIIa for post-operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodies. British Journal of Haematology, 114, 245246.
  • Poon, M.C., Demers, C., Jobin, F. & Wu, J.W.Y. (1999) Recombinant Factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood, 94, 39513953.
  • Poon, M.C., D'Oiron, R. & members of the International Registry on Recombinant factor VIIa and Congenital Platelet Disorders Group (2000) Recombinant activated factor VII (Novoseven) treatment of platelet-related bleeding disorders. Blood Coagulation and Fibrinolysis, 11, s55s68.
  • Roberts, H.R. (2001) Recombinant factor VIIa (NovoSeven®) and the safety of treatment. Seminars in Hematology, 38, 4850.
  • Snyder, H.W., Cochran, S.K., Balint, J.P., Bertram, J.H., Mittelman, A., Guthrie, T.H. & Jones, F.R. (1992) Experience with protein A immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura. Blood, 79, 22372245.
  • Tchernia, G., Morel-Kopp, M.C., Yvart, J. & Kaplan, C. (1993) Neonatal thrombocytopenia and hidden maternal autoimmunity. British Journal of Haematology, 84, 457463.
  • Tengborn, L. & Petruson, B. (1996) A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thrombosis and Haemostasis, 75, 981982.
  • Vivier, M., Treisser, A., Naett, M., Diemunsch, P., Scmitt, J.P., Waller, C., Tongio, M.M., Hemmendinger, S. & Lutz, P. (1989) Glanzmann's thrombasthenia and pregnancy. Contribution of plasma exchange before scheduled cesarean section. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 18, 507513.
  • Watt, R.M., Bunitsky, K., Faulkner, E.B., Hart, C.M., Horan, J., Ramstack, J.M., Viola, J.L. & Yordy, J.R. (1992) Treatment of congenital and acquired hemophilia patients by extracorporeal removal of antibodies to coagulation factors: a review of US clinical studies 1987–90. Hemophilia Study Group. Transfusion Science, 13, 233253.
  • Wielenga, J.J., Siebel, Y., Van Buuren, H.R., Berends, F.J., Schipperus, M.R., Van Vliet, H.D.D.M. & Kappers, M.C. (1998) Use of recombinant factor VIIa and HLA matched platelets to prevent bleeding during and after major surgery in a patient with Glanzmann's thrombasthenia. Haemophilia, 4, 299a.